DEA delays kratom ban, more Senators object to process and ‘unintended consequences’
“The alkaloids have been known for over a decade to possess some modest opioid actions but their potential benefit for patients with chronic pain and substance dependence was overlooked in the (DEA) notice of intent to place the botanical chemicals in the same class as heroin, LSD and mescaline.” Columbia associate research scientist, Andrew Kruegel,…
Recent Comments